Clinical Trial Update: Megestrol Acetate Plus Metformin to Megestrol Acetate in Patients With Endometrial Atypical Hyperplasia or Early Stage Endometrial Adenocarcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on megestrol acetate with metformin in endometrial atypical hyperplasia and early-stage endometrial adenocarcinoma; study complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Adenocarcinoma
• Endometrial Atypical Hyperplasia

Drugs mentioned

• Megestrol acetate (megestrol acetate)
• metformin (metformin)

Snippet

Sponsor: Xiaojun Chen | Conditions: Endometrial Atypical Hyperplasia, Endometrial Adenocarcinoma | Phase 2 | Status: COMPLETED | Results posted: 2021-09-13